Pitcairn’s Loxo Oncology, Inc LOXO Stock Holding History

Pitcairn’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,835	Closed	-$257K	–	541
2018 Q4	$257K	Sell	1,835 -133	-7%	-$20.2K	0.03%	352
2018 Q3	$336K	Sell	1,968 -95	-5%	-$16K	0.03%	372
2018 Q2	$358K	Buy	+2,063	New	+$310K	0.04%	342

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Pitcairn's LOXO Position: Q1 2019 in Review

Pitcairn sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,835 shares — an estimated $257K sold.

Pitcairn first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $358K in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Pitcairn reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Pitcairn sold 1,835 Loxo Oncology, Inc shares in Q1 2019, an estimated $257K.
Pitcairn first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
Pitcairn's Loxo Oncology, Inc position peaked at $358K in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Pitcairn's 13F filing for Q1 2019, filed 7 May 2019.